Seòmar agus comataidhean

The Scottish Government is not considering the introduction of sanctions for any contractor which breaches its NHS contract at present. The National Health Service (Pharmaceutical Services) (Scotland) Regulations 2009, set out the provision of NHS pharmaceutical services and requirements for those entered on the Boards Pharmaceutical List.

The Achieving Excellence in Pharmaceutical Care strategy, published in 2017, commits the Scottish Government to review contractual arrangements and as such may consider the introduction of sanctions as part of any future strategy framework.

The community pharmacy network is a vital part of the primary care team. The Scottish Government continues to work with Community Pharmacy Scotland and other partners to ensure not only the stability of the network but also that a balance is maintained across the whole pharmacy workforce in the hospital, community, and GP practice sectors.

The Chief Pharmaceutical Officer has committed to putting together a workforce forum which will meet in early 2022. The forum will look at the workforce challenges and bring together stakeholders from pharmacy education and pharmacy service provision to set a strategic workforce plan for the profession.

There are no plans to introduce protected learning time at present. It is a decision for employers to allow staff time to study for additional qualifications.

To support delivery of the Community Pharmacy First Plus service, Community Pharmacist contractors receive backfill (up to £5750) to release community pharmacists to undertake their IP qualification (5 days face to face teaching + 12 days Period of Learning in Practice), clinical skills training (4 days) and also access to a maximum of 3 sessions at a CCC Teach and Treat Training Hub (backfill up to £750).

The pharmacy profession and provision of pharmaceutical care is regulated by the General Pharmaceutical Council, who assure and improve standards of care for people using pharmacy services. The Achieving Excellence in Pharmaceutical Care strategy, published in 2017, setting out the priorities, commitments, and actions for improving and integrating NHS pharmaceutical care in Scotland up to 2022. The strategy sets the direction for how pharmaceutical care would be delivered in Scotland and the crucial contribution of pharmacists and pharmacy technicians, working together with other health and social care practitioners, to improve the health of the population and impact on health outcomes.

All NHS Boards across Scotland have the option of referring patients to the NHS Centre for Integrative Care (CIC) for services not available locally.

It is for individual NHS Boards to decide what complementary and alternative medicines/therapies they make available based on the needs of their resident populations and in line with national guidance.

The CIC is a facility owned and operated by NHS Greater Glasgow and Clyde (NHS GGC), offering people with long term conditions a range of services, including complementary, holistic and homeopathic treatments. It is the responsibility of NHS GGC to manage access to their services.

The Scottish Government recognises that Complementary and Alternative Medicines Services (CAMS), may offer relief to some people suffering from a wide variety of conditions.

It is for individual NHS Boards to decide what complementary and alternative medicines/therapies they make available based on the needs of their resident populations and in line with national guidance.

The NHS Centre for Integrative Care (CIC) is a facility owned, operated and funded by NHS Greater Glasgow and Clyde (NHS GGC). It offers people with long term conditions a range of services, including complementary, holistic and homeopathic treatments. Most patients referred to the centre are experiencing chronic pain, chronic low energy, and/or chronic low mood or anxiety.

The NHS Centre for Integrative Care (CIC) is a facility that all NHS Boards across Scotland have the option of referring patients to for services not available locally.

The Scottish Government is providing £12.4 billion for frontline NHS boards, which is a £327 million (3.2%) increase. This is the first step to ensuring that frontline funding - which directly supports patient services - increases by at least £2.5 billion by 2026-27.

Over 50% of frontline spend will go towards community health services, delivering on our commitment to increase primary care funding by 25% over this Parliament, providing more care for people in a place and way that meets their needs.

The Scottish Government continues to work with Health Boards, Community Pharmacy Scotland and other stakeholders across the sector to address any challenges faced by temporary closures of community pharmacies.

The Chief Pharmaceutical Officer has committed to putting together a workforce forum which will meet in early 2022. The forum will look at the workforce challenges and bring together stakeholders from pharmacy education and pharmacy service provision to set a strategic workforce plan for the profession.

Because of the unpredictable lifecycle of this particular organism, it is not possible to routinely test buildings for an Aspergillus infection. Where water ingress creates the conditions for mould, NHS Greater Glasgow and Clyde’s staff work to remedy faults as soon as they are found and remove any mould with oversight from Infection Prevention and Control (IPC). Patients with Aspergillus are visited by an infection prevention and control nurse. Advice on the correct antibiotics to administer to patients is given by a Microbiology/ICD/antimicrobial pharmacist on request of the clinical teams.

A variety of risk assessments are undertaken across all wards in the Hospital, including 4a and 4b, covering social distancing, hand hygiene, infection control precautions (SICPs) audits every 6 months, patient placement, and the verification of the specialist ventilation systems in ward 4b. The new and innovative Infection Prevention and Control (IPC) dashboard available to all staff enables real time review of IPC data, and allows for a quick and effective response to any risks reported.